These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

424 related articles for article (PubMed ID: 34512721)

  • 1. The Emerging Role of Non-coding RNAs in Drug Resistance of Ovarian Cancer.
    Lan H; Yuan J; Zeng D; Liu C; Guo X; Yong J; Zeng X; Xiao S
    Front Genet; 2021; 12():693259. PubMed ID: 34512721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent advances of non-coding RNAs in ovarian cancer prognosis and therapeutics.
    Chen M; Lei N; Tian W; Li Y; Chang L
    Ther Adv Med Oncol; 2022; 14():17588359221118010. PubMed ID: 35983027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Noncoding RNAs in gastric cancer: implications for drug resistance.
    Wei L; Sun J; Zhang N; Zheng Y; Wang X; Lv L; Liu J; Xu Y; Shen Y; Yang M
    Mol Cancer; 2020 Mar; 19(1):62. PubMed ID: 32192494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The emerging role of noncoding RNAs in colorectal cancer chemoresistance.
    Wei L; Wang X; Lv L; Zheng Y; Zhang N; Yang M
    Cell Oncol (Dordr); 2019 Dec; 42(6):757-768. PubMed ID: 31359293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel Implications of MicroRNAs, Long Non-coding RNAs and Circular RNAs in Drug Resistance of Esophageal Cancer.
    Wei L; Sun J; Zhang N; Shen Y; Wang T; Li Z; Yang M
    Front Cell Dev Biol; 2021; 9():764313. PubMed ID: 34881242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of non-coding RNAs in chemotherapy resistance of ovarian cancer.
    Shao Y; Li H; Du R; Meng J; Yang G
    J Cancer; 2018; 9(11):1966-1972. PubMed ID: 29896281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Role of Non-Coding RNAs in Breast Cancer Drug Resistance.
    Tian JH; Liu SH; Yu CY; Wu LG; Wang LB
    Front Oncol; 2021; 11():702082. PubMed ID: 34589423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Noncoding RNAs in drug-resistant pancreatic cancer: A review.
    Lin Z; Lu S; Xie X; Yi X; Huang H
    Biomed Pharmacother; 2020 Nov; 131():110768. PubMed ID: 33152930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Role of Non-Coding RNAs in the Sorafenib Resistance of Hepatocellular Carcinoma.
    Hu X; Zhu H; Shen Y; Zhang X; He X; Xu X
    Front Oncol; 2021; 11():696705. PubMed ID: 34367979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-coding RNA in drug resistance of gastric cancer.
    Luo YJ; Huang QM; Ren Y; Liu ZL; Xu CF; Wang H; Xiao JW
    World J Gastrointest Oncol; 2019 Nov; 11(11):957-970. PubMed ID: 31798777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-Coding RNAs in Gastric Cancer: From Malignant Hallmarks to Clinical Applications.
    Chen D; Ping S; Xu Y; Wang M; Jiang X; Xiong L; Zhang L; Yu H; Xiong Z
    Front Cell Dev Biol; 2021; 9():732036. PubMed ID: 34805143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-Coding RNAs: Uncharted Mediators of Thyroid Cancer Pathogenesis.
    Tabatabaeian H; Peiling Yang S; Tay Y
    Cancers (Basel); 2020 Nov; 12(11):. PubMed ID: 33158279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Non-Coding RNAs Inducing Drug Resistance in Ovarian Cancer: A New Perspective for Understanding Drug Resistance.
    Li G; Gong J; Cao S; Wu Z; Cheng D; Zhu J; Huang X; Tang J; Yuan Y; Cai W; Zhang H
    Front Oncol; 2021; 11():742149. PubMed ID: 34660304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The emerging role of circular RNAs in cisplatin resistance in ovarian cancer: From molecular mechanism to future potential.
    Malek Mohammadi M; Rismanchi H; Esmailzadeh S; Farahani A; Hedayati N; Alimohammadi M; Mafi A; Farahani N; Hushmandi K
    Noncoding RNA Res; 2024 Dec; 9(4):1280-1291. PubMed ID: 39040815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-coding RNAs in Lung Cancer Chemoresistance.
    Mondal P; Natesh J; Kamal MA; Meeran SM
    Curr Drug Metab; 2019; 20(13):1023-1032. PubMed ID: 31906835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Emerging Role of Major Regulatory RNAs in Cancer Control.
    Dai X; Kaushik AC; Zhang J
    Front Oncol; 2019; 9():920. PubMed ID: 31608229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Network of Non-coding RNAs in Cancer Drug Resistance.
    Corrà F; Agnoletto C; Minotti L; Baldassari F; Volinia S
    Front Oncol; 2018; 8():327. PubMed ID: 30211115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An update on current and emerging therapies for epithelial ovarian cancer: Focus on poly(adenosine diphosphate-ribose) polymerase inhibition and antiangiogenesis.
    Chung C; Lee R
    J Oncol Pharm Pract; 2017 Sep; 23(6):454-469. PubMed ID: 27357817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The emerging role of microRNAs and long noncoding RNAs in drug resistance of hepatocellular carcinoma.
    Wei L; Wang X; Lv L; Liu J; Xing H; Song Y; Xie M; Lei T; Zhang N; Yang M
    Mol Cancer; 2019 Oct; 18(1):147. PubMed ID: 31651347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-Coding RNAs Delivery by Small Extracellular Vesicles and Their Applications in Ovarian Cancer.
    Liu M; Zhou X; Tang J
    Front Bioeng Biotechnol; 2022; 10():876151. PubMed ID: 35662846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.